| The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients. (NCT00356148) | Marmara University | 2003-10-01 |
| Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer (NCT00060320) | Alliance for Clinical Trials in Oncology | 2003-10-01 |
| FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients (NCT00129389) | Spanish Breast Cancer Research Group | 2003-09-19 |
| Harvesting Cells for Experimental Cancer Treatments (NCT00068003) | National Cancer Institute (NCI) | 2003-09-08 |
| Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer (NCT00078832) | Queen Mary University of London | 2003-09-01 |
| Survival TRaining for ENhancing Total Health (STRENGTH) (NCT00068458) | Duke University | 2003-09-01 |
| Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer (NCT00080301) | R-Pharm | 2003-09-01 |
| Component and Couple Analysis of Cancer Communications (NCT00468741) | University of Wisconsin, Madison | 2003-09-01 |
| Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery (NCT00311636) | Gruppo Italiano Mammella (GIM) | 2003-09-01 |
| Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer (NCT00336791) | M.D. Anderson Cancer Center | 2003-09-01 |
| Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer (NCT00154882) | National Taiwan University Hospital | 2003-09-01 |
| Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer (NCT00074139) | Case Comprehensive Cancer Center | 2003-09-01 |
| Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ (NCT00072462) | Queen Mary University of London | 2003-09-01 |
| Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women (NCT00742755) | Jonsson Comprehensive Cancer Center | 2003-09-01 |
| TBP Study With Capecitabine Plus Minus Trastuzumab (NCT00148876) | GBG Forschungs GmbH | 2003-09-01 |
| Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer (NCT00083018) | Royal Marsden NHS Foundation Trust | 2003-09-01 |
| Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer (NCT00080626) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2003-08-11 |
| 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection (NCT00068263) | Radiation Therapy Oncology Group | 2003-08-01 |
| The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer (NCT00047970) | National Institute of Environmental Health Sciences (NIEHS) | 2003-08-01 |
| Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy (NCT00074100) | Memorial Sloan Kettering Cancer Center | 2003-08-01 |
| Premenopausal Endocrine Responsive Chemotherapy Trial (NCT00066807) | ETOP IBCSG Partners Foundation | 2003-08-01 |
| Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer (NCT00160901) | Heidelberg University | 2003-08-01 |
| Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer (NCT00072020) | University of Sheffield | 2003-08-01 |
| Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screening (NCT00131950) | National Cancer Institute (NCI) | 2003-08-01 |
| Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy (NCT00499057) | University Of Perugia | 2003-08-01 |
| Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer (NCT00068757) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-08-01 |
| Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development (NCT00381927) | Baystate Medical Center | 2003-08-01 |
| Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00072319) | Memorial Sloan Kettering Cancer Center | 2003-08-01 |
| Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer (NCT00068328) | Alliance for Clinical Trials in Oncology | 2003-08-01 |
| Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk (NCT00043472) | National Cancer Institute (NCI) | 2003-07-09 |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy (NCT00063570) | Eli Lilly and Company | 2003-07-01 |
| Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer (NCT00068341) | Jonsson Comprehensive Cancer Center | 2003-07-01 |
| Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer (NCT00209001) | Emory University | 2003-07-01 |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer (NCT00146562) | Harold J. Burstein, MD, PhD | 2003-07-01 |
| Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer (NCT00083031) | Dana-Farber Cancer Institute | 2003-07-01 |
| A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer (NCT00077857) | Hoffmann-La Roche | 2003-07-01 |
| Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer (NCT00201773) | Ohio State University Comprehensive Cancer Center | 2003-07-01 |
| Nipple Areola Complex Conservation (NCT00641628) | Technical University of Munich | 2003-07-01 |
| Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment (NCT00565305) | University of Iowa | 2003-07-01 |
| HER-2 Protein Vaccine in Treating Women With Breast Cancer (NCT00068614) | Case Comprehensive Cancer Center | 2003-07-01 |
| GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer (NCT00144898) | Hospices Civils de Lyon | 2003-07-01 |
| ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment (NCT00331097) | National Cancer Institute, Naples | 2003-07-01 |
| Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer (NCT00074269) | University of California, San Diego | 2003-07-01 |
| Ph II Early BC Pre-Surgical Biologic Study (NCT00637026) | AstraZeneca | 2003-07-01 |
| Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine (NCT00156312) | University of Michigan Rogel Cancer Center | 2003-07-01 |
| Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients (NCT00206492) | Baylor Breast Care Center | 2003-07-01 |
| Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer (NCT00066573) | NCIC Clinical Trials Group | 2003-06-06 |
| Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer (NCT00072865) | Eli Lilly and Company | 2003-06-01 |
| Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer (NCT00437853) | Instituto Nacional de Cancerologia de Mexico | 2003-06-01 |
| Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer (NCT00176488) | University of Medicine and Dentistry of New Jersey | 2003-06-01 |
| Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer (NCT00054145) | University Health Network, Toronto | 2003-06-01 |
| Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer (NCT00431795) | Hellenic Oncology Research Group | 2003-06-01 |
| Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer (NCT00107393) | Tohoku University | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy (NCT00070031) | Memorial Sloan Kettering Cancer Center | 2003-06-01 |
| Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer (NCT00202059) | HealthPartners Institute | 2003-06-01 |
| Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) (NCT00095706) | Translational Oncology Research International | 2003-06-01 |
| A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy (NCT00328432) | University of Kansas | 2003-06-01 |
| Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane (NCT00059852) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors (NCT00278837) | Weill Medical College of Cornell University | 2003-05-01 |
| Study of MDX-010 in Stage IV Breast Cancer (NCT00083278) | Bristol-Myers Squibb | 2003-05-01 |
| Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy (NCT00066339) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-05-01 |
| Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer (NCT00062400) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-05-01 |
| Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer (NCT00066378) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-05-01 |
| Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery (NCT00251329) | Cancer Research Network | 2003-05-01 |
| Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy (NCT00066547) | Jonsson Comprehensive Cancer Center | 2003-05-01 |
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. (NCT00171340) | Novartis Pharmaceuticals | 2003-05-01 |
| Adherence to Intensive Surveillance for Hereditary Breast Cancer (NCT00582803) | Memorial Sloan Kettering Cancer Center | 2003-05-01 |
| Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer (NCT00065533) | Eli Lilly and Company | 2003-05-01 |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors (NCT00471432) | NCIC Clinical Trials Group | 2003-04-04 |
| Fatigue in Breast Cancer: A Behavioral Sleep Intervention (NCT00572416) | University of Nebraska | 2003-04-01 |
| Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients (NCT00440622) | Hellenic Oncology Research Group | 2003-04-01 |
| Protocol for Women at Increased Risk of Developing Breast Cancer (NCT00291694) | Carol Fabian, MD | 2003-04-01 |
| Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer (NCT00645866) | Mayo Clinic | 2003-04-01 |
| Breast Cancer in Pregnancy Register Study (NCT00196833) | GBG Forschungs GmbH | 2003-04-01 |
| Phase II Study for Solid Metastatic Tumors (NCT02474186) | NYU Langone Health | 2003-04-01 |
| Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women (NCT00084344) | Northwestern University | 2003-04-01 |
| Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer (NCT00433420) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2003-04-01 |
| Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer (NCT00182728) | UNC Lineberger Comprehensive Cancer Center | 2003-03-18 |
| Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations (NCT00579007) | Memorial Sloan Kettering Cancer Center | 2003-03-11 |
| Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" (NCT00201890) | Ontario Clinical Oncology Group (OCOG) | 2003-03-01 |
| Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer (NCT00054418) | Alliance for Clinical Trials in Oncology | 2003-03-01 |
| Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer (NCT00198237) | Indiana University | 2003-03-01 |
| A Study of Patients With HER2-Positive Metastatic Breast Cancer (NCT00105456) | Genentech, Inc. | 2003-03-01 |
| Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients (NCT00128856) | Spanish Breast Cancer Research Group | 2003-03-01 |
| Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer (NCT00898690) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2003-03-01 |
| High-Risk Breast Duct Epithelium (NCT00028340) | National Cancer Institute (NCI) | 2003-02-20 |
| Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer (NCT00045591) | Alliance for Clinical Trials in Oncology | 2003-02-01 |
| Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer (NCT00086749) | Northwestern University | 2003-02-01 |
| Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors (NCT00054977) | Galectin Therapeutics Inc. | 2003-02-01 |
| Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients (NCT00429247) | University Hospital of Crete | 2003-02-01 |
| Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer (NCT00191789) | Eli Lilly and Company | 2003-02-01 |
| Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients (NCT00129376) | Spanish Breast Cancer Research Group | 2003-02-01 |
| Genetic Counseling in African American Women (NCT00419510) | University of Pennsylvania | 2003-02-01 |
| Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS (NCT00324714) | ETOP IBCSG Partners Foundation | 2003-02-01 |
| Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer (NCT00058058) | American College of Radiology Imaging Network | 2003-02-01 |
| Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole (NCT00237224) | Novartis Pharmaceuticals | 2003-02-01 |
| A Study of Pertuzumab in Participants With Metastatic Breast Cancer (NCT02491892) | Hoffmann-La Roche | 2003-02-01 |
| Study of Health Effects of Cosmetic Breast Augmentation (NCT00342953) | National Cancer Institute (NCI) | 2003-01-10 |
| Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin (NCT00162812) | Jules Bordet Institute | 2003-01-01 |